Term ends Aug 10, 2031 · High confidence
20-year base term ends Apr 12, 2031
Filed Sep 13, 2018 as application 16/130,242 · Granted Feb 27, 2024
Base term plus 839 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2011
2031
Clock starts
Apr 12, 2011
Apr 12, 2011
Term ends
Aug 10, 2031
Aug 10, 2031
Granted
Feb 27, 2024
Feb 27, 2024
base term
patent term adjustment
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
839
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,105,372.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 839 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 1 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 12, 2011, when application 13/085,338, the earliest non-provisional in its chain, was filed (this one was filed Sep 13, 2018) | Apr 12, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +839 days, USPTO patent term adjustment record | Jul 29, 2033 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,105,372) | capped to Aug 10, 2031 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 10, 2031 | High confidence |
This family
| US 10,105,372 | Lapsed on the fee record Oct 2026 | Oct 2026 |
| US 11,911,395 | this patent Aug 2031 | Aug 2031 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 26, 2018 Reel 46974, frame 731 | Meyer, Colin J.; Huff, J. Warren | Reata Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 4, 2022 Reel 58639, frame 138 | Reata Pharmaceuticals, Inc. | Reata Pharmaceuticals Holdings, LLC | Assignment of Assignor's Interest |
| May 18, 2023 Reel 63697, frame 461 | Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc. | Biopharma Credit PLC | Patent Security Agreement |
| Jul 12, 2023 Reel 64264, frame 557 | Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc. | Biopharma Credit PLC | Amended and Restated Patent Security Agreement |
| Apr 9, 2025 Reel 70793, frame 228 | Biopharma Credit PLC | Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc. | Release of Security Interest |
| Apr 9, 2025 reel/frame not recorded | Biopharma Credit PLC | Reata Pharmaceuticals Holdings, LLC | Release of Security Interest |
| Apr 9, 2025 reel/frame not recorded | Biopharma Credit PLC | Reata Pharmaceuticals Global, Inc. | Release of Security Interest |
| Apr 9, 2025 reel/frame not recorded | Biopharma Credit PLC | Reata Pharmaceuticals, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Aug 2031
Term ends Aug 10, 2031. Maintenance fees still fall due before then
Note
The 839 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,105,372.
Citations
2
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.